Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Oxx in connection with the establishment of Oxx II
Mandate

Vinge has advised Oxx in connection with the establishment of Oxx II

December 07, 2023 Private Funds

Oxx closes its second fund generation with USD 190 million in commitments from an international investor base, and thereby increases the fund size by 40% since its latest fund announcement.

Oxx was founded in 2017 and primarily invests in European companies within the B2B SaaS scale-up space.
Vinge’s team primarily consisted of Mattias Schömer, Jesper Ottergren, Viveka Classon, Martin Cronsioe, Semir Omerbasic and Viktoria Wnuk.

Related

Vinge advised Precise Biometrics

 Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

 Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026